Yongkui Lu

Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma

Yihebali Chi, Zhiwei Fang, Xiaonan Hong et al. · Clinical Cancer Research · 2018 · 322 citations

Hypoxia-inducible factor 1 alpha promotes cancer stem cells-like properties in human ovarian cancer cells by upregulating SIRT1 expression

Jie Qin, Yan Liu, Yongkui Lu et al. · Scientific Reports · 2017 · 120 citations · Full text

Mesenchymal Stem Cell-Secreted Exosome Promotes Chemoresistance in Breast Cancer via Enhancing miR-21-5p-Mediated S100A6 Expression

Tao Luo, Qiaoyuan Liu, Aihua Tan et al. · Molecular Therapy — Oncolytics · 2020 · 70 citations · Full text

Anlotinib for metastasis soft tissue sarcoma: A randomized, double-blind, placebo-controlled and multi-centered clinical trial.

Yihebali Chi, Yang Yao, Shusen Wang et al. · Journal of Clinical Oncology · 2018 · 64 citations

Surgical Oncology, Multi-centered Clinical Trial, Tumoral Pathology +13

Inhibition of autophagy enhances the radiosensitivity of nasopharyngeal carcinoma by reducing Rad51 expression

Ning Mo, Yongkui Lu, Weimin Xie et al. · Oncology Reports · 2014 · 54 citations · Full text